معرفی
Amos de Jong is a postdoctoral researcher at the Julius Center for Health Sciences and Primary Care within the University Medical Center Utrecht. His work focuses on regulatory science and clinical trial innovation, with a particular emphasis on decentralized and adaptive platform trials. He employs mixed-method approaches to address methodological and operational challenges in clinical research.
- Education: PhD in Drug Innovation from Utrecht University (2024)
Research Interests include decentralized clinical trials, regulatory frameworks for adaptive trial designs, and optimizing operational methodologies in clinical research. His work intersects clinical epidemiology and health policy, aiming to improve trial efficiency and patient inclusivity.
Recent Publications (2023-2025) analyze low-intervention trials under EU regulation, operational challenges in post-authorization RCTs, and efforts to standardize terminology in decentralized trial approaches. Key themes span regulatory compliance, methodological innovation, and digital health integration.
